Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis

References

• Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57
   PubMed Web of Science ®Google Scholar
• Farrell TJ, Peppercorn MA. Ulcerative colitis. Lancet 2002;359:331-40
   PubMed Web of Science ®Google Scholar
• Büsch K, Ludvigsson JF, Ekström-Smedby K, et al. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther 2014;39(1):57-68
   PubMed Web of Science ®Google Scholar
• Kawalec P, Mikrut A, Wiśniewska N, et al. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn’s disease: systematic review and meta-analysis. Arch Med Sci 2013;9(5):765-79
   PubMed Web of Science ®Google Scholar
• Kawalec P, Mikrut A, Łopuch S. Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis. J Gastroenterol Hepatol 2014;29(6):1159-70
   PubMedGoogle Scholar
• Nguyen GC, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis 2007;13:1529-35
   PubMed Web of Science ®Google Scholar
• Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics 2014;32(4):335-44
   PubMed Web of Science ®Google Scholar
• Thomas T, Cohen RD. Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies. Expert Rev Gastroenterol Hepatol 2007;1(1):101-12
   PubMedGoogle Scholar
• Zhao FL, Xie F, Hu H, et al. Transferability of indirect cost of chronic disease: a systematic review and meta-analysis. Pharmacoeconomics 2013;31(6):501-8
   PubMed Web of Science ®Google Scholar
• GDP per capita, PPP (current international $) World Development Indicators database. World Bank. Database updated on 16 December 2014. [Accessed on 20 December 2014]
   Google Scholar
• Available from: http://handbook.cochrane.org
   Google Scholar
• Mandel MD, Bálint A, Lovász BD, et al. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Eur J Health Econ 2014;15(Suppl 1):S121-8
   PubMed Web of Science ®Google Scholar
• Benedini V, Caporaso N, Corazza GR, et al. Burden of Crohn’s disease: economics and quality of life aspects in Italy. Clinicoecon Outcomes Res 2012;4:209-18
   PubMedGoogle Scholar
• Juan J, Estiarte R, Colome E, et al. Burden of illness of Crohn’s disease in Spain. Dig Liver Dis 2003;35(12):853-61
   PubMedGoogle Scholar
• Lion M, Gearry RB, Day AS, et al. The cost of paediatric and perianal Crohn’s disease in Canterbury, New Zealand. N Z Med J 2012;125(1349):11-20
   PubMedGoogle Scholar
• Mesterton J, Jönsson L, Almer SH, et al. Resource use and societal costs for Crohn’s disease in Sweden. Inflamm Bowel Dis 2009;15(12):1882-90
   PubMed Web of Science ®Google Scholar
• Loftus EV, Guérin A, Tsaneva M, et al. Direct and Indirect Economic Burdens and Impact On Salary Growth of Moderate to Severe Crohn’s Disease. Gastroenterology 2009;136(5 Suppl 1):A26-7
   PubMedGoogle Scholar
• Sandborn WJ, Colombel JF, Louis E, et al. Economic impact of deep remission in adalimumab-treated patients with Crohn’s disease: results from extend. Gastroenterology 2011;140(5 Suppl 1):S205
   Google Scholar
• Cohen R, Rizzo J. Yang M at al. Direct and Indirect Utilization and Costs Associated with Ulcerative Colitis. Am J Gastroenterol 2012;107:S608-95
   Google Scholar
• Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24(8):797-814
   PubMed Web of Science ®Google Scholar
• Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004;53(10):1471-8
   PubMed Web of Science ®Google Scholar
• Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997;32(11):1134-9
   PubMed Web of Science ®Google Scholar
• Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309-17
   PubMed Web of Science ®Google Scholar
• Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn’s disease and ulcerative colitis. J Occup Environ Med 2008;50(11):1261-72
   PubMed Web of Science ®Google Scholar
• Longobardi T, Jacobs P, Bernstein CN. Work losses related to IBD in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064-72
   PubMed Web of Science ®Google Scholar
• Longobardi T, Jacobs P, Wu L, et al. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol 2003;98(4):844-9
   PubMed Web of Science ®Google Scholar
• Lofland J, Naim A, Rizzo JA, et al. The indirect costs of inflammatory bowel disease: evidence from United States National Survey Data. Gastroenterology 2010;138(5 Suppl 1):S317
   Google Scholar
• Naim A, Nair KV, Van Den Bos J, et al. Comparison of total health care expenditures and absenteeism for inflammatory bowel disease from an employer’s perspective. Value Health 2010;3:A207
   Google Scholar
• van der Valk ME, Mangen MJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut 2014;63(1):72-9
   PubMed Web of Science ®Google Scholar
• Cohen RD, Yu AP, Wu EQ, et al. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 2010;31(7):693-707
   PubMed Web of Science ®Google Scholar
• Yu AP, Cabanilla LA, Wu EQ, et al. The costs of Crohn’s disease in the United States and other Western countries: a systematic review. Curr Med Res Opin 2008;24(2):319-28
   PubMed Web of Science ®Google Scholar
• Odes S. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol 2008;14(43):6641-7
   PubMed Web of Science ®Google Scholar